Loestrin 24 fe what is it

You should also not take oral contraceptives soon after delivery of a baby. It is advisable to wait for at least four weeks after delivery if you are not breastfeeding. The risk of circulatory disease in oral contraceptive users may be higher in users of high-dose pills containing 50 micrograms or higher of ethinyl estradiol and may be greater with longer duration of oral contraceptive use. In addition, some of these increased risks may continue for a number of years after stopping oral contraceptives.

The risk of abnormal blood clotting increases with age in both users and nonusers of oral contraceptives, but the increased risk from the oral contraceptive appears to be present at all ages.

For women aged 20 to 44 it is estimated that about 1 in 2, using oral contraceptives will be hospitalized each year because of abnormal clotting. Among nonusers in the same age group, about 1 in 20, would be hospitalized each year. For oral contraceptive users in general, it has been estimated that in women between the ages of 15 and 34 the risk of death due to a circulatory disorder is about 1 in 12, per year, whereas for nonusers the rate is about 1 in 50, per year.

In the age group 35 to 44, the risk is estimated to be about 1 in 2, per year for oral contraceptive users and about 1 in 10, per year for nonusers. Oral contraceptives may increase the tendency to develop strokes stoppage or rupture of blood vessels in the brain and angina pectoris and heart attacks blockage of blood vessels in the heart.

Any of these conditions can cause death or disability. Smoking greatly increases the possibility of suffering heart attacks and strokes. Furthermore, smoking and the use of oral contraceptives greatly increase the chances of developing and dying of heart disease. Women with migraine especially migraine with aura who take oral contraceptives also may be at higher risk of stroke. Oral contraceptive users probably have a greater risk than nonusers of having gallbladder disease, although this risk may be related to pills containing high doses of estrogens.

In rare cases, oral contraceptives can cause benign but dangerous liver tumors. These benign liver tumors can rupture and cause fatal internal bleeding. In addition, a possible, but not definite, association has been found with the pill and liver cancers in two studies, in which a few women who developed these very rare cancers were found to have used oral contraceptives for long periods.

However, liver cancers in general are extremely rare, and the chance of developing liver cancer from using the pill is thus even rarer. This small increase in the number of breast cancer diagnoses gradually disappears during the 10 years after stopping use of the pill. Women who currently have or have had breast cancer should not use oral contraceptives because breast cancer is usually a hormone-sensitive tumor.

Some studies have found an increase in the incidence of cancer or precancerous lesions of the cervix in women who use oral contraceptives. However, this finding may be related to factors other than the use of oral contraceptives. There is insufficient evidence to rule out the possibility that the pill may cause such cancers. In patients with inherited defects of lipid metabolism, there have been reports of significant elevations of plasma triglycerides during estrogen therapy.

This has led to pancreatitis in some cases. All methods of birth control and pregnancy are associated with a risk of developing certain diseases which may lead to disability or death. An estimate of the number of deaths associated with different methods of birth control and pregnancy has been calculated and is shown in the following table.

In the above table, the risk of death from any birth control method is less than the risk of childbirth, except for oral contraceptive users over the age of 35 who smoke and pill users over the age of 40 even if they do not smoke. It can be seen in the table that for women aged 15 to 39, the risk of death was highest with pregnancy 7 to 26 deaths per , women, depending on age. Among pill users who do not smoke, the risk of death was always lower than that associated with pregnancy for any age group less than Over the age of 40, the risk increases to 32 deaths per , women, compared to 28 deaths associated with pregnancy in that age group.

However, for pill users who smoke and are over the age of 35, the estimated number of deaths exceeds those associated with pregnancy. The suggestion that women over 40 who don't smoke should not take oral contraceptives is based on information from older high-dose pills. An Advisory Committee of the FDA discussed this issue in and recommended that the benefits of oral contraceptive use by healthy, nonsmoking women over 40 years of age may outweigh the possible risks.

Older women, as all women who take oral contraceptives, should take an oral contraceptive which contains the least amount of estrogen and progestin that is compatible with the individual patient needs. If any of these adverse conditions occur while you are taking oral contraceptives, call your healthcare provider immediately:. Irregular vaginal bleeding or spotting may occur while you are taking Loestrin 24 Fe Irregular bleeding may vary from slight staining between menstrual periods to breakthrough bleeding which is a flow much like a regular period.

Irregular bleeding occurs most often during the first few months of oral contraceptive use, but may also occur after you have been taking the pill for some time. Such bleeding may be temporary and usually does not indicate any serious problems. It is important to continue taking your pills on schedule. If the bleeding occurs in more than one cycle or lasts for more than a few days, talk to your healthcare provider. If you wear contact lenses and notice a change in vision or an inability to wear your lenses, contact your healthcare provider.

Oral contraceptives may cause edema fluid retention with swelling of the fingers or ankles and may raise your blood pressure. If you experience fluid retention, contact your healthcare provider. A spotty darkening of the skin is possible, particularly of the face. The darkening may persist after stopping the pill.

Other side effects may include nausea and vomiting, change in appetite, breast tenderness, headache, nervousness, depression, dizziness, loss of scalp hair, rash, vaginal infections, and allergic reactions. Missed periods and use of oral contraceptives before or during early pregnancy. There may be times when you may not menstruate regularly after you have completed taking a cycle of pills. If you have taken your pills regularly and miss one menstrual period, continue taking your pills for the next cycle but be sure to inform your healthcare provider.

If you have not taken the pills daily as instructed and missed a menstrual period, or if you missed two consecutive menstrual periods, you may be pregnant. Check with your healthcare provider immediately to determine whether you are pregnant. Stop taking Loestrin 24 Fe if you are pregnant. There is no conclusive evidence that oral contraceptive use is associated with an increase in birth defects when taken inadvertently during early pregnancy.

Previously, a few studies had reported that oral contraceptives might be associated with birth defects but these studies have not been confirmed. Nevertheless, oral contraceptives should not be used during pregnancy. You should check with your healthcare provider about risks to your unborn child of any medication taken during pregnancy.

If you are breastfeeding, consult your healthcare provider before starting oral contraceptives. Some of the drug will be passed on to the child in the milk. A few adverse effects on the child have been reported, including yellowing of the skin jaundice and breast enlargement. In addition, oral contraceptives may decrease the amount and quality of your milk. If possible, do not use oral contraceptives while breastfeeding.

You should use another method of contraception since breastfeeding provides only partial protection from becoming pregnant, and this partial protection decreases significantly as you breastfeed for longer periods of time.

You should consider starting oral contraceptives only after you have weaned your child completely. If you are scheduled for any laboratory tests, tell your healthcare provider you are taking birth control pills. Certain blood tests may be affected by birth control pills. Certain drugs may interact with birth control pills to make them less effective in preventing pregnancy or cause an increase in breakthrough bleeding.

Pregnancies and breakthrough bleeding have been reported by users of combined hormonal contraceptives who also used some form of the herbal supplement St. You may need to use a non-hormonal method of contraception during any cycle in which you take drugs that can make oral contraceptives less effective. Be sure to tell your healthcare provider if you are taking or start taking any other medications, including nonprescription products or herbal products while taking birth control pills.

It does not protect against transmission of HIV AIDS and other sexually transmitted diseases such as Chlamydia, genital herpes, genital warts, gonorrhea, hepatitis B, and syphilis.

If pregnancy does occur, the risk to the fetus is minimal. There may be some delay in becoming pregnant after you stop using oral contraceptives, especially if you had irregular menstrual cycles before you used oral contraceptives. It may be advisable to postpone conception until you begin menstruating regularly once you have stopped taking the pill and desire pregnancy. There does not appear to be any increase in birth defects in newborn babies when pregnancy occurs soon after stopping the pill.

Serious ill effects have not been reported following ingestion of large doses of oral contraceptives by young children. Overdosage may cause nausea and withdrawal bleeding in females. In case of overdosage, contact your healthcare provider or pharmacist. You should be reexamined at least once a year.

Be sure to inform your healthcare provider if there is a family history of any of the conditions listed previously in this leaflet. Be sure to keep all appointments with your healthcare provider, because this is a time to determine if there are early signs of side effects of oral contraceptive use. Do not use this drug for any condition other than the one for which it was prescribed. This drug has been prescribed specifically for you; do not give it to others who may want birth control pills.

In addition to preventing pregnancy, use of oral contraceptives may provide certain benefits. They are:. If you want more information about birth control pills, ask your healthcare provider or pharmacist.

They have a more technical leaflet called the Professional Labeling, which you may wish to read. Each white tablet contains norethindrone acetate, 1 mg; ethinyl estradiol, 20 mcg; each brown tablet contains ferrous fumarate 75 mg; each blister card contains 24 white tablets and 4 brown tablets. Usual Dosage--One tablet daily for 28 days as directed by the physician. See bottom flap for lot number and expiration date.

Ferrous fumarate tablets are not USP for dissolution and assay. DailyMed will deliver notification of updates and additions to Drug Label information currently shown on this site through its RSS feed.

DailyMed will deliver this notification to your desktop, Web browser, or e-mail depending on the RSS Reader you select to use. Due to inconsistencies between the drug labels on DailyMed and the pill images provided by RxImage , we no longer display the RxImage pill images associated with drug labels.

We anticipate reposting the images once we are able identify and filter out images that do not match the information provided in the drug labels. View Package Photos. Drug Label Info. This is a repackaged label. The structural formulas for the active hormones are:. Absorption Norethindrone acetate appears to be completely and rapidly deacetylated to norethindrone after oral administration, because the disposition of norethindrone acetate is indistinguishable from that of orally administered norethindrone.

Table 1. TABLE 2 Percentage of women experiencing an unintended pregnancy during the first year of typical use and the first year of perfect use of contraception and the percentage continuing use at the end of the first year. United States. Oral contraceptives should not be used in women who currently have the following conditions: Thrombophlebitis or thromboembolic disorders A past history of deep vein thrombophlebitis or thromboembolic disorders Cerebrovascular or coronary artery disease current or history Valvular heart disease with thrombogenic complications Severe hypertension Diabetes with vascular involvement Headaches with focal neurological symptoms Major surgery with prolonged immobilization Known or suspected carcinoma of the breast or personal history of breast cancer Carcinoma of the endometrium or other known or suspected estrogen-dependent neoplasia Undiagnosed abnormal genital bleeding Cholestatic jaundice of pregnancy or jaundice with prior pill use Hepatic adenomas or carcinomas, or active liver disease Known or suspected pregnancy Hypersensitivity to any component of this product.

Myocardial Infarction An increased risk of myocardial infarction has been attributed to oral contraceptive use. Smoking in combination with oral contraceptive use has been shown to contribute substantially to the incidence of myocardial infarctions in women in their mid-thirties or older, with smoking accounting for the majority of excess cases.

Mortality rates associated with circulatory disease have been shown to increase substantially in smokers over the age of 35 and nonsmokers over the age of 40 Figure 3 among women who use oral contraceptives. Anti-infective agents and anticonvulsants Contraceptive effectiveness may be reduced when hormonal contraceptives are co-administered with antibiotics, anticonvulsants, and other drugs that increase the metabolism of contraceptive steroids.

Anti-HIV protease inhibitors Several of the anti-HIV protease inhibitors have been studied with co-administration of oral combination hormonal contraceptives; significant changes increase and decrease in the plasma levels of the estrogen and progestin have been noted in some cases. Herbal products Herbal products containing St. Changes in plasma levels of co-administered drugs: Combination hormonal contraceptives containing some synthetic estrogens e. Increased thyroid-binding globulin TBG leading to increased circulating total thyroid hormone, as measured by protein-bound iodine PBI , T 4 by column or by radioimmunoassay.

Free T 3 resin uptake is decreased, reflecting the elevated TBG, free T 4 concentration is unaltered. Other binding proteins may be elevated in serum. Sex hormone binding globulins are increased and result in elevated levels of total circulating sex steroids and corticoids; however, free or biologically active levels remain unchanged. Triglycerides may be increased and levels of various other lipids and lipoproteins may be affected.

Glucose tolerance may be decreased. Serum folate levels may be depressed by oral contraceptive therapy. This may be of clinical significance if a woman becomes pregnant shortly after discontinuing oral contraceptives. Effects on menses: Increased menstrual cycle regularity Decreased blood loss and decreased incidence of iron-deficiency anemia Decreased incidence of dysmenorrhea Effects related to inhibition of ovulation: Decreased incidence of functional ovarian cysts Decreased incidence of ectopic pregnancies Effects from long-term use: Decreased incidence of fibroadenomas and fibrocystic disease of the breast Decreased incidence of acute pelvic inflammatory disease Decreased incidence of endometrial cancer Decreased incidence of ovarian cancer.

During the first cycle of use: The possibility of ovulation and conception prior to initiation of medication should be considered. Switching from another hormonal method of contraception: When the patient is switching to Loestrin 24 Fe after completing a day regimen of oral contraceptive tablets, transdermal patches, or a vaginal ring, she should wait 7 days after her last tablet, patch, or ring before she starts Loestrin 24 Fe. If spotting or breakthrough bleeding occurs: The patient is instructed to continue on the same regimen.

Use after pregnancy, abortion or miscarriage: Loestrin 24 Fe should be initiated no earlier than 28 days postpartum in the nonlactating mother due to the increased risk for thromboembolism. NDC - blister cards Rx only Keep this drug and all drugs out of the reach of children.

References are available upon request. The risks associated with taking oral contraceptives increase significantly if you: Smoke Have high blood pressure, diabetes, high cholesterol, or are obese Have or have had clotting disorders, heart attack, stroke, angina pectoris severe chest pains , cancer of the breast or sex organs, jaundice, or malignant or benign liver tumors You should not take the pill if you are pregnant or have unexplained vaginal bleeding.

Risk of developing blood clots Blood clots and blockage of blood vessels are the most serious side effects of taking oral contraceptives and can cause death or serious disability. Heart attacks and strokes Oral contraceptives may increase the tendency to develop strokes stoppage or rupture of blood vessels in the brain and angina pectoris and heart attacks blockage of blood vessels in the heart.

Gallbladder disease Oral contraceptive users probably have a greater risk than nonusers of having gallbladder disease, although this risk may be related to pills containing high doses of estrogens.

Liver tumors In rare cases, oral contraceptives can cause benign but dangerous liver tumors. Cancer of the breast and reproductive organs Breast cancer has been diagnosed slightly more often in women who use the pill than in women of the same age who do not use the pill. Lipid metabolism and inflammation of the pancreas In patients with inherited defects of lipid metabolism, there have been reports of significant elevations of plasma triglycerides during estrogen therapy.

If you miss pills you could get pregnant. This includes starting the pack late. The more pills you miss, the more likely you are to get pregnant. If you have spotting or light bleeding or feel sick to your stomach, do not stop taking the pill.

The problem will usually go away. If it doesn't go away, check with your healthcare provider. On the days you take 2 pills to make up for missed pills, you could also feel a little sick to your stomach. Use a back-up method of birth control such as condoms or spermicide until you check with your healthcare provider. This package is not child resistant. Keep this and all drugs out of the reach of children. Version Files Mar 12, 1 current download.

NDC 1 inactivated. John's wort. Always discuss with your doctor or Nurx advisor anything you're taking, whether it's over the counter or not, before starting Loestrin 24 Fe. Read More. Loestrin 24 Fe. Request A Prescription.

Why Nurx? Product details We love Loestrin 24 Fe for its mid-level estrogen levels and helpful daily doses of iron. Download Nulled WordPress Themes. Premium WordPress Themes Download. Download WordPress Themes Free. Active Ingredients Ethinyl estradiol estrogen [0. Risks Do not take if pregnant. Do not take if you have a family history of blood clots. Not suitable for smokers over Increased risk for blood clots. Increased risk for stroke and heart attack. We are doctors, nurses, nurse practitioners, pharmacists, and physician assistants who are passionate about providing patient care.

The Nurx medical team believes that everyone deserves access to personalized, non-judgmental healthcare, and that open and honest communication is key. How It Works. Select your medication, or get guidance from our medical team. Answer a few questions and enter your insurance info if you have coverage - if not, no problem. A Nurx provider in your state will review your request and write a prescription, if appropriate. For questions about the program, including savings on mail order prescriptions, please call 1.

When you redeem this card, you certify that you have not submitted and will not submit a claim for reimbursement under any federal, state, or other government programs for this prescription. Reimbursement will be received from Change Healthcare. Lo Loestrin Fe norethindrone acetate and ethinyl estradiol tablets, ethinyl estradiol tablets and ferrous fumarate tablets is a prescription birth control pill used for the prevention of pregnancy.

Register online. You are now leaving loloestrin. Who should not take Lo Loestrin Fe? What else should I know about taking Lo Loestrin Fe? What are the most serious risks of taking Lo Loestrin Fe? What are the possible side effects of Lo Loestrin Fe?

Program Terms, Conditions and Eligibility Criteria:. Allergan reserves the right to rescind, revoke, or amend this offer without notice. Void if prohibited by law, taxed, or restricted. This offer is not health insurance. This card expires December 31,